Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A randomised trial comparing 8 cycles of CPT11 with CPT11 until disease progression in patients with Colorectal Cancer resistant to 5-Fluorouracil (5FU)
Source of recordUK Trials
ISRCTNISRCTN59568483
Date ISRCTN assigned19/08/2002
Local reference number(s)RMH E/C 1475
Public titleA randomised trial comparing 8 cycles of CPT11 with CPT11 until disease progression in patients with Colorectal Cancer resistant to 5-Fluorouracil (5FU)
Scientific title
AcronymN/A
Disease/condition/study domainColon, Rectum
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Histological evidence of metastatic adenocarcinoma of colon or rectum not amenable to surgery or radiotherapy
2. Documented evidence of disease progression by Computed Tomography (CT) within 24 weeks of last 5FU
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date16/10/1997
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsTwo arms:
1. CPT11 350 mg/m2 IV over 30 min every 3 weeks
2. No treatment
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingRoyal Marsden Hospital
Sponsor nameRoyal Marsden Hospital (UK)
Sponsor detailsDowns Road
Sutton
United Kingdom
SM2 5PT
Sponsor telephone+44 (0)20 8661 3156
Sponsor fax+44 (0)20 8643 9414
Sponsor websitedavid.cunningham@rmh.nhs.uk
Contact nameDr - -
Contact detailsUKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Contact telephone+44 (0) 20 7670 4723
Contact fax+44 (0) 20 7670 4818
Contact emailregister@ctu.mrc.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN59568483
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central